HB Wealth Management LLC Purchases 3,880 Shares of Cigna Group $CI

HB Wealth Management LLC raised its holdings in shares of Cigna Group (NYSE:CI) by 25.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 19,146 shares of the health services provider’s stock after purchasing an additional 3,880 shares during the quarter. HB Wealth Management LLC’s holdings in Cigna Group were worth $5,107,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently modified their holdings of the business. Wilkerson Advisory Group LLC bought a new position in shares of Cigna Group in the fourth quarter worth $25,000. Beacon Financial Strategies CORP bought a new stake in shares of Cigna Group during the 4th quarter valued at $28,000. Kemnay Advisory Services Inc. bought a new stake in shares of Cigna Group during the 4th quarter valued at $29,000. Prosperity Bancshares Inc purchased a new stake in Cigna Group during the 4th quarter worth about $29,000. Finally, Lodestone Wealth Management LLC purchased a new stake in Cigna Group during the 4th quarter worth about $32,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Activity at Cigna Group

In other news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.60% of the company’s stock.

Cigna Group Price Performance

Shares of NYSE CI opened at $287.50 on Monday. The stock’s 50-day simple moving average is $285.09 and its two-hundred day simple moving average is $279.26. Cigna Group has a twelve month low of $239.51 and a twelve month high of $323.10. The firm has a market capitalization of $76.05 billion, a P/E ratio of 12.19, a P/E/G ratio of 1.11 and a beta of 0.29. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. During the same quarter last year, the company posted $6.74 EPS. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities analysts anticipate that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th were given a dividend of $1.56 per share. The ex-dividend date was Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s payout ratio is presently 26.45%.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on CI shares. Raymond James Financial set a $340.00 target price on Cigna Group in a report on Friday, May 1st. Royal Bank Of Canada increased their price target on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a report on Friday, May 1st. Cantor Fitzgerald raised their price objective on shares of Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research report on Friday, May 1st. Jefferies Financial Group reduced their price objective on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a research note on Monday, April 20th. Finally, Barclays lowered shares of Cigna Group from an “overweight” rating to an “equal weight” rating and decreased their target price for the stock from $310.00 to $304.00 in a report on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $338.30.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.